Multaq Uses

Multaq is licensed to treat atrial fibrillation and atrial flutter in adults. Specifically, it is used to minimize the risk of heart-related hospitalizations in people who have these types of irregular heart rhythms, have other cardiovascular risk factors, have recently had an episode, and currently have a normal heart rhythm. Healthcare providers may also occasionally recommend off-label uses of Multaq, such as for treating other arrhythmias.

What Is Multaq Used For?

Multaq® (dronedarone) is a prescription arrhythmia medicine approved for the treatment of the following medical conditions:
Specifically, it is approved to reduce the risk of heart-related hospitalization in people who meet all of the following criteria:
  • Have atrial fibrillation or atrial flutter
  • Have other cardiovascular risk factors, such as:



  • Have had a recent episode of atrial fibrillation or atrial flutter (within the past six months)
  • Currently have a normal heart rhythm (or are about to be converted to a normal heart rhythm).
Multaq is not approved for people currently in atrial fibrillation or atrial flutter. Instead, it is used to help people stay in "normal sinus rhythm."
Multaq must not be used in people whose heart rhythm cannot be converted to normal ("permanent atrial fibrillation"). Studies have shown that Multaq doubles the risk of heart failure and heart-related death and increases the risk of stroke in people with permanent atrial fibrillation. Your healthcare provider should check your heart rhythm every three months to make sure your atrial fibrillation has not returned.
Ouch! 6 Types of Pain You Might Experience When Getting a Stent

Multaq Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.